Clinical Trial: Evaluating a Single 1600 mg Tablet Regimen of 5‐Aminosalicylate for Ulcerative Colitis—The <scp>EASI</scp> Trial
The study was registered at Clinicaltrials.gov (ID NCT04133194) and approved by The Danish Medicine Agency and The National Committee on Health Research Ethics (EudraCT 2019-002070-31).
Authors
- Johan M. Burisch (ORCID: https://orcid.org/0000-0002-3312-5139)
- Katarzyna Majchrzak (ORCID: https://orcid.org/0000-0003-4152-441X)
- Rie Louise Møller Nordestgaard (ORCID: https://orcid.org/0009-0002-1991-8295)
- Flemming Bendtsen (ORCID: https://orcid.org/0000-0002-8419-2104)
- Ida Vind
- Bobby Zhao Sheng Lo (ORCID: https://orcid.org/0000-0002-0252-9341)
- Signe Krogsgaard Holme
- Reinhold Bergström (ORCID: https://orcid.org/0009-0001-9458-4945)
- Izabella Adzioski
- Ida Marie Hawwa
- Bermal Tiftikci
- Helene Skotte
Institutions
- University of Copenhagen (DK)
- Amager Hospital (DK)
- Hvidovre Hospital (DK)
- Copenhagen University Hospital (DK)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1111/apt.70375
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Tillotts Pharma